Schedule 13D ownership disclosure
Actuate Therapeutics Inc
Security class unavailable · CUSIP: 005083100
Event date: 2024-08-14
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 525,797
- Percent of class
- 2.8000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-24-090990
- Form type
- SC 13D
- Filer
- ACTUATE THERAPEUTICS, INC.
- CIK
- CIK 1652935
- Filed
- Aug 19, 2024
- Reporting period
- Aug 14, 2024
- Description
- Schedule 13D beneficial ownership